ResMed | RMD - Trade Creditors

Stock Price
263.03
Daily Change
11.62 4.62%
Monthly
7.20%
Yearly
8.43%
Q1 Forecast
250.35

ResMed reported $250.41M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Ansell USD 250.9M 25.4M Jun/2025
AtriCure USD 74.84M 8.91M Sep/2025
Baxter International USD 953M 42M Sep/2025
Cochlear AUD 298.4M 12.9M Jun/2025
Cooper Companies USD 300.4M 44.5M Sep/2025
CSL USD 3.46B 484M Jun/2025
Dexcom USD 451.5M 20.5M Sep/2025
Edwards Lifesciences USD 165M 94.2M Sep/2025
Fisher Paykel Healthcare NZD 267.8M 4M Dec/2025
Globus Medical USD 87.23M 128K Sep/2025
Haemonetics USD 61.69M 15.68M Sep/2025
Hologic USD 201.1M 573.5M Dec/2025
Idexx Laboratories USD 122.26M 5.68M Sep/2025
Insulet USD 48.2M 47.9M Sep/2025
Integra LifeSciences USD 92.3M 530K Sep/2025
Intuitive Surgical USD 1.92B 179.7M Dec/2025
Masimo USD 117.9M 17.8M Sep/2025
Medtronic USD 2.56B 106M Jun/2025
Philips EUR 1.71B 39M Sep/2025
Ramsay Health Care AUD 1.73B 76.3M Jun/2025
ResMed USD 250.41M 16.37M Dec/2025
Sigma Healthcare AUD 1.32B 970.03M Dec/2025
Sonic Healthcare AUD 313.54M 543.93M Jun/2024
Steris USD 308.9M 8M Sep/2025
Teleflex USD 165.91M 8.35M Sep/2025
Thermo Fisher Scientific USD 3.12B 140M Sep/2025